Haytham O. Tawfik
Tanda, GH, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Quinazolinone-triazole hybrids as multi-target-directed ligands for Alzheimer's disease: discovery of potent and selective MAO-B inhibitors with cholinesterase modulating activity.
Journal: RSC advances
Published: July 07, 2026
Targeting CDK-2 With Novel Indole-Pyrazole Hybrids: Discovery of Potent Anticancer Agents Supported by Mechanistic and In Silico Studies.
Journal: Drug development research
Published: June 14, 2026
Correction: Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity.
Journal: Frontiers in pharmacology
Published: May 30, 2026
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.
Journal: Drug development research
Published: April 08, 2026
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP-1/EGFR Inhibitors.
Journal: Drug development research
Published: March 26, 2026
Development of novel chalcone-based quinazoline derivatives as dual VEGFR-2 and EGFR inhibitors.
Journal: RSC medicinal chemistry
Published: March 04, 2026
Patents involving monoamine oxidase (MAO): a comprehensive update (2022-2025) on its inhibitors and applications.
Journal: Expert opinion on therapeutic patents
Published: February 16, 2026
Thiazole-Semicarbazone Hybrids as Dual-Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic Insights.
Journal: Drug development research
Published: January 12, 2026
Pharmacophore modeling: advances and pitfalls.
Journal: Frontiers in molecular biosciences
Published: December 04, 2025
Identification of Benzenesulfonamide-Containing Thiazolidine-2,4-Dione Derivatives as Novel Carbonic Anhydrase II and VII Inhibitors with Anti-Epileptic Activity.
Journal: Journal of medicinal chemistry
Published: December 03, 2025
Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 19, 2025
In silico pipeline for GSK 3β inhibitor discovery in Alzheimer's disease using pharmacophore screening, docking, ADME filtering, and MD validation.
Journal: Scientific reports
Published: November 19, 2025
Last Updated: 09/26/2026